Did you have any side effects with this medicine?
What is Metronidazole?
Metronidazole is used to treat bacterial infections in different areas of the body. The extended-release tablets are used to treat women with vaginal infections (bacterial vaginosis).
Metronidazole belongs to the class of medicines known as antibiotics. It works by killing bacteria or preventing their growth. However, Metronidazole will not work for colds, flu, or other virus infections.
Metronidazole is available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, Metronidazole is used in certain patients with the following medical conditions:
- Clostridium difficile diarrhea or colitis (antibiotic-associated colitis).
- Crohn's disease (inflammatory bowel disease).
- Gastritis or stomach ulcers due to Helicobacter pylori.
- Giardiasis (parasite infection in the intestines).
Metronidazole is indicated for the treatment of symptomatic trichomoniasis in females and males when the presence of thetrichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures).
Metronidazole is indicated in the treatment of asymptomatic females when the organism is associated with endocervi-citis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite.
Treatment of Asymptomatic Consorts.
T. vagi-nalis infection is a venereal disease. Therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. The decision as to whether to treat an asymptomatic male partner who has a negative culture or one for whom no culture has been attempted is an individual one. In making this decision, it should be noted that there is evidence that a woman may become reinfected if her consort is not treated. Also, since there can be considerable difficulty in isolating the organism from the asymptomatic male carrier, negative smears and cultures cannot be relied upon in this regard. In any event, the consort should be treated with Metronidazole in cases of reinfection.
Metronidazole is indicated in the treatment of acute intestinal amebiasis (amebic dysen-tery)and amebic liver abscess.
In amebic liver abscess, Metronidazole therapy does not obviate the need for aspiration or drainage of pus.
Anaerobic Bacterial Infections
Metronidazole is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with Metronidazole therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to Metronidazole.
In the treatment of most serious anaerobic infections, Metronidazole I.V. (Metronidazole hydrochloride) or Metronidazole I.V. RTU® (Metronidazole) is usually administered initially. This may be followed by oral ther-apy with Metronidazole at the discretion of the physician.
INTRA-ABDOMINAL INFECTIONS, including peritonitis, intra-abdominal abscess, and liver abscess, caused by Bacteroides species including the B. fragilis group (B. fragilis, B. distasonis,B. ovatus, B. thetaiotaomicron, B. vulgatus), Clostrid-ium species, Eubacterium species, Peptococcus niger, and Peptostreptococcus species.
SKIN AND SKIN STRUCTURE INFECTIONS caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus niger,Peptostreptococcus species, and Fusobacte-rium species.
GYNECOLOGIC INFECTIONS, including endo-metritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection, caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcusniger, and Pepto-streptococcus species.
BACTERIAL SEPTICEMIA caused by Bacteroides species including the B. fragilis group, and Clos-tridium species.
BONE AND JOINT INFECTIONS, as adjunctive therapy, caused by Bacteroides species including the B. fragilis group.
CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS, including meningitis and brain abscess, caused by Bacteroides species including the B.fragilis group.
LOWER RESPIRATORY TRACT INFECTIONS, including pneumonia, empyema, and lung abscess, caused by Bacteroides species including the B. fragilis group.
ENDOCARDITIS caused by Bacteroides species including the B.fragilis group.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole and other antibacterial drugs, Metronidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
How should I use Metronidazole?
Use Metronidazole gel as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- An extra patient leaflet is available with Metronidazole gel. Talk to your pharmacist if you have questions about this information.
- If you are using Metronidazole gel once daily, use it at bedtime.
- Remove the cap from the tube and break the metal seal on the tube with the pointed tip of the cap. Screw the end of the applicator onto the tube. Slowly squeeze gel out of the tube and into the applicator. The plunger will stop when the applicator is full. Unscrew applicator and replace the cap on the tube.
- You may insert Metronidazole gel lying on your back with your knees bent or in any comfortable position. Hold the filled applicator by the barrel, and gently insert into the vagina as far as it will comfortably go. Slowly press the plunger until it stops, and then remove the applicator.
- If you will be using Metronidazole gel twice daily, you will need to clean the applicator after your first dose of the day and use it again for your second dose. To clean the applicator, pull the plunger out of the barrel. Wash both the plunger and barrel in warm, soapy water and rinse well. To put the applicator back together, gently push the plunger back into the barrel.
- Wash your hands immediately after using Metronidazole gel.
- When you throw the applicator away, be sure that it is out of the reach of children and pets.
- Using Metronidazole gel at the same time each day will help you remember to use it.
- To clear up your infection completely, use Metronidazole gel for the full course of treatment. Keep using it even if you feel better in a few days.
- If you miss a dose of Metronidazole gel, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Metronidazole gel.
Uses of Metronidazole in details
Use: Labeled Indications
Amebiasis: Treatment of acute intestinal amebiasis (amebic dysentery) and extraintestinal amebiasis (liver abscess)
Limitations of use: When used for amebic liver abscess, may be used concurrently with percutaneous needle aspiration when clinically indicated.
Anaerobic bacterial infections (caused by Bacteroides spp., including the B. fragilis group):
Bacterial septicemia: Treatment of bacterial septicemia (also caused by Clostridium spp.)
Bone and joint infections: Treatment (adjunctive therapy) of bone and joint infections
CNS Infections: Treatment of CNS infections, including meningitis and brain abscess
Endocarditis: Treatment of endocarditis
Gynecologic infections: Treatment of gynecologic infections including endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection (also caused by Clostridium spp., Peptococcus spp., Peptostreptococcus spp., and Fusobacterium spp.)
Intra-abdominal infections: Treatment of intra-abdominal infections, including peritonitis, intra-abdominal abscess, and liver abscess (also caused by Clostridium spp., Eubacterium spp., Peptococcus spp., and Peptostreptococcus spp.)
Lower respiratory tract infections: Treatment of lower respiratory tract infections, including pneumonia, empyema, and lung abscess
Skin and skin structure infections: Treatment of skin and skin structure infections (also caused by Clostridium spp., Peptococcus spp., Peptostreptococcus spp., and Fusobacterium spp.)
Surgical prophylaxis (colorectal surgery): Injection: Preoperative, intraoperative, and postoperative prophylaxis to reduce the incidence of postoperative infection in patients undergoing elective colorectal surgery classified as contaminated or potentially contaminated
Trichomoniasis: Treatment of infections caused by Trichomonas vaginalis, including treatment of asymptomatic sexual partners
Off Label Uses
Data from a single case report of one immunocompromised patient with pulmonary infection treated with Metronidazole suggest that Metronidazole may be beneficial for the treatment of balantidiasis.
Each 100 mL contains Metronidazole USP 500 mg, sodium chloride USP 0.72% w/v, water for injection USP as needed.
Metronidazole injection, USP is a parenteral dosage form of the synthetic antibacterial agent 1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole. The empirical formula is C6H9N3O3 and the molecular weight is 171.15.
Metronidazole injection, USP in 100 mL is a sterile, nonpyrogenic, iso-osmotic, buffered solution of 500 mg Metronidazole, USP, 790 mg sodium chloride, USP, 47.6 mg dried dibasic sodium phosphate, USP and 22.9 mg anhydrous citric acid, USP. Metronidazole injection, USP has an osmolarity of 310 mOsmol/L (calc) and a pH of 5.5 (4.5 to 7).
Usual Adult Dose for Acne Rosacea
Metronidazole topical 1% gel or cream: Apply a thin film to the affected area once a day.
Metronidazole topical 0.75% gel, cream, or lotion: Apply a thin film to the affected area twice a day.
Usual Adult Dose for Bacterial Vaginosis
Insert one applicatorful of Metronidazole topical 0.75% vaginal gel intravaginally once (at bedtime) or twice a day for 5 consecutive days.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Gel, cream, lotion: Data not available
Vaginal gel: The manufacturer recommends caution when administering this drug to patients with severe hepatic disease.
The duration of topical therapy is 4 to 10 weeks depending on the nature and severity of the condition.
Patients should be advised to use Metronidazole topical less frequently or discontinue use if a reaction suggesting local irritation occurs.
Convulsive seizures and peripheral neuropathy have been reported in patients receiving oral or IV Metronidazole. If abnormal neurologic signs appear, Metronidazole topical vaginal gel should be discontinued at once. The use of Metronidazole topical 1% gel should be reevaluated at once if abnormal neurologic signs appear. Metronidazole topical should be used with caution in patients with central nervous system diseases.
Metronidazole topical should be used with caution in patients with evidence of, or history of blood dyscrasia.
Although disulfiram-like reactions have not been reported in patients receiving vaginal Metronidazole, the manufacturer recommends that alcohol be avoided. Metronidazole topical vaginal gel should not be used in patients who have taken disulfiram within the last 2 weeks.
Safety and efficacy have not been established in pediatric patients (less than 18 years of age).
Data not available
Metronidazole topical may cause eye irritation if applied too close to the eyes. Contact with the eyes should be avoided.
Topical areas to be treated should be washed with a mild cleanser prior to application.
The manufacturer recommends avoidance of vaginal intercourse during treatment with Metronidazole topical vaginal gel.
Psychotic reactions have been reported in alcoholic patients who are using Metronidazole and disulfiram concurrently. Metronidazole should not be given to patients who have taken disulfiram within the last two weeks.
Abdominal cramps, nausea, vomiting, headaches, and flushing may occur if alcoholic beverages or products containing propylene glycol are consumed during or following Metronidazole therapy.
Warfarin And Other
Metronidazole has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. When Metronidazole is prescribed for patients on this type of anticoagulant therapy, prothrombin time and INR should be carefully monitored.
In patients stabilized on relatively high doses of lithium, short-term Metronidazole therapy has been associated with elevation of serum lithium and, in a few cases, signs of lithium toxicity. Serum lithium and serum creatinine levels should be obtained several days after beginning Metronidazole to detect any increase that may precede clinical symptoms of lithium intoxication.
Metronidazole has been reported to increase plasma concentrations of busulfan, which can result in an increased risk for serious busulfan toxicity. Metronidazole should not be administered concomitantly with busulfan unless the benefit outweighs the risk. If no therapeutic alternatives to Metronidazole are available, and concomitant administration with busulfan is medically needed, frequent monitoring of busulfan plasma concentration should be performed and the busulfan dose should be adjusted accordingly.
Drugs That Inhibit CYP450 Enzymes
The simultaneous administration of drugs that decrease microsomal liver enzyme activity, such as cimetidine, may prolong the half-life and decrease plasma clearance of Metronidazole.
Drugs That Induce CYP450 Enzymes
The simultaneous administration of drugs that induce microsomal liver enzymes, such as phenytoin or phenobarbital, may accelerate the elimination of Metronidazole, resulting in reduced plasma levels; impaired clearance of phenytoin has also been reported.
Drug/Laboratory Test Interactions
Metronidazole may interfere with certain types of determinations of serum chemistry values, such as aspartate aminotransferase (AST, SGOT), alanine aminotransferase (ALT, SGPT), lactate dehydrogenase (LDH), triglycerides, and glucose hexokinase. Values of zero may be observed. All of the assays in which interference has been reported involve enzymatic coupling of the assay to oxidation-reduction of nicotinamide adenine dinucleotide (NAD- NADH). Interference is due to the similarity in absorbance peaks of NADH (340 nm) and Metronidazole (322 nm) at pH 7.
Metronidazole side effects
Two serious adverse reactions reported in patients treated with Metronidazole have been convulsive seizures and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity. Since persistent peripheral neuropathy has been reported in some patients receiving prolonged administration of Metronidazole, patients should be specifically warned about these reactions and should be told to stop the drug and report immediately to their physicians if any neu-rologic symptoms occur.
The most common adverse reactions reported have been referable to the gastrointestinal tract, particularly nausea reported by about 12% of patients, sometimes accompanied by headache, anorexia, and occasionally vomiting; diarrhea; epi-gastric distress; and abdominal cramping. Constipation has also been reported.
The following reactions have also been reported during treatment with Metronidazole:
Mouth: A sharp, unpleasant metallic taste is not unusual. Furry tongue, glossitis, and sto-matitis have occurred; these may be associated with a sudden overgrowth of Candida which may occur during therapy.
Hematopoietic: Reversible neutropenia (leuko-penia); rarely, reversible thrombocytopenia.
Cardiovascular: Flattening of the T-wave may be seen in electrocardiographic tracings.
Central Nervous System: Convulsive seizures, peripheral neuropathy, dizziness, vertigo, incoordination, ataxia, confusion, irritability, depression, weakness, and insomnia.
Hypersensitivity: Urticaria, erythematous rash, flushing, nasal congestion, dryness of the mouth (or vagina or vulva), and fever.
Renal: Dysuria, cystitis, polyuria, incontinence, and a sense of pelvic pressure. Instances of darkened urine have been reported by approximately one patient in 100,000. Although the pigment which is probably responsible for this phenomenon has not been positively identified, it is almost certainly a metabolite of Metronidazole and seems to have no clinical significance.
Other: Proliferation of Candida in the vagina, dyspareunia, decrease of libido, proctitis, and fleeting joint pains sometimes resembling &ldquoserum sickness.” If patients receiving Metronidazole drink alcoholic beverages, they may experience abdominal distress, nausea, vomiting, flushing, or headache. A modification of the taste of alcoholic beverages has also been reported. Rare cases of pan-creatitis, which generally abated on withdrawal of the drug, have been reported.
Crohn’s disease patients are known to have an increased incidence of gastrointestinal and certain extraintestinal cancers. There have been some reports in the medical literature of breast and colon cancer in Crohn’s disease patients who have been treated with Metronidazole at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn’s disease is not an approved indication for Metronidazole.
Metronidazole Capsules 375 mg are contraindicated in patients with a prior history of hypersensitivity to Metronidazole or other nitroimidazole derivatives.
In patients with trichomoniasis, Metronidazole Capsules 375 mg are contraindicated during the first trimester of pregnancy.
Psychotic Reaction with Disulfiram
Use of oral Metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. Do not administer Metronidazole to patients who have taken disulfiram within the last two weeks.
Interaction with Alcohol
Use of oral Metronidazole is associated with a disulfiram-like reaction to alcohol, including abdominal cramps, nausea, vomiting, headaches, and flushing. Discontinue consumption of alcohol or products containing propylene glycol during and for at least three days after therapy with Metronidazole.
Active ingredient matches for Metronidazole:
|Unit description / dosage (Manufacturer)||Price, USD|
|Injectable; Injection; Metronidazole 5 mg / ml|
|Tablet; Oral; Metronidazole 250 mg|
|Gel; Topical; Metronidazole 0.75%|
|Gel; Vaginal; Metronidazole 0.75%|
|Capsule; Oral; Metronidazole 500 mg|
|Tablet; Oral; Metronidazole 500 mg|
|Suspension; Oral; Metronidazole Benzoate 320 mg / 5 ml|
|Capsule; Oral; Metronidazole 375 mg|
|Cream; Topical; Metronidazole 0.75%|
|Lotion; Topical; Metronidazole 0.75%|
|Suppositories; Vaginal; Metronidazole 100 mg|
|Gel; Vaginal; Metronidazole 1%|
|Suppositories; Vaginal; Metronidazole 500 mg|
|Suppositories; Rectal; Metronidazole 1 g|
|Suppositories; Rectal; Metronidazole 500 mg|
|Tablet; Oral; Metronidazole 200 mg|
|Tablet; Oral; Metronidazole 400 mg|
|Tablet, Extended Release; Oral; Metronidazole 750 mg|
|MetroLotion 0.75% Lotion 59ml Bottle||$ 292.66|
|MetroCream 0.75% Cream 45 gm Tube||$ 281.09|
|Metrogel 1% Gel 60 gm Tube||$ 200.93|
|Metrogel 1% Kit Box||$ 200.93|
|Metrogel 1% kit||$ 193.20|
|Noritate 1% Cream 60 gm Tube||$ 156.44|
|MetroNIDAZOLE 0.75% Lotion 59ml Bottle||$ 89.86|
|MetroNIDAZOLE 0.75% Cream 45 gm Tube||$ 80.87|
|MetroNIDAZOLE 0.75% Gel 45 gm Tube||$ 74.00|
|MetroNIDAZOLE 0.75% Gel 70 gm Tube||$ 68.53|
|Flagyl ER 750 mg 24 Hour tablet||$ 13.20|
|Flagyl er 750 mg tablet||$ 12.70|
|MetroNIDAZOLE 750 mg 24 Hour tablet||$ 8.07|
|Flagyl 500 mg tablet||$ 6.24|
|Metrocream 0.75% cream||$ 5.99|
|Danazol 200 mg capsule||$ 5.63|
|Flagyl 375 mg capsule||$ 5.45|
|Metrolotion topical 0.75%||$ 4.77|
|Metronidazole benz powder||$ 4.74|
|Flagyl 250 mg tablet||$ 3.49|
|Danazol 100 mg capsule||$ 2.98|
|Noritate 1% cream||$ 2.51|
|Danazol 50 mg capsule||$ 1.99|
|Metronidazole powder||$ 1.65|
|Metronidazole 0.75% cream||$ 1.34|
|Metronidazole vaginal 0.75% gl||$ 0.94|
|Metronidazole 500 mg tablet||$ 0.72|
|Metrogel 0.75 % Gel||$ 0.69|
|Metrogel 1 % Gel||$ 0.63|
|Noritate 1 % Cream||$ 0.58|
|Rosasol 1 % Cream||$ 0.57|
|Metrocream 0.75 % Cream||$ 0.52|
|Metrolotion 0.75 % Lotion||$ 0.52|
|Metrogel-vaginal 0.75% gel||$ 0.51|
|Vandazole vaginal 0.75% gel||$ 0.48|
|Metronidazole 250 mg tablet||$ 0.44|
|Flagyl 10 % Cream||$ 0.25|
|Apo-Metronidazole 250 mg Tablet||$ 0.06|
|Flagyl 5 mg/ml||$ 0.03|
|Metro iv 500 mg/100 ml||$ 0.03|
|Metronidazole 5 mg/ml||$ 0.03|
|Metronidazole 500 mg/100 ml||$ 0.03|
|Metronidazole / Fresenius Kabi 0.5 % x 100 mL|
|Metronidazole / Sinphar 250 mg x 1000's|
|Metronidazole / Sinphar 250 mg x 100 x 10's|
|Metronidazole / Yu Sheng 250 mg|
|Metronidazole / CCPC 5 mg/1 mL x 100 mL|
|Metronidazole / CCPC 5 mg/1 mL x 200 mL|
|Metronidazole / CCPC 5 mg/1 mL x 500 mL|
|Metronidazole / Shinlon 250 mg|
|Metronidazole / Shinlon 250 mg x Blister pk|
|Metronidazole / C.H. 250 mg|
|Tablets; Oral; Metronidazole 250 mg|
|Capsules; Oral; Metronidazole 500 mg|
|Capsules; Oral; Metronidazole 375 mg|
|Tablets, Extended Release; Oral; Metronidazole 750 mg|
|Tablets; Oral; Metronidazole 500 mg|
|Injectable; Infusion; Metronidazole 5 mg / ml|
|Tablets; Oral; Metronidazole 200 mg|
|Tablets; Oral; Metronidazole 400 mg|
|METRONIDAZOLE / ALB. DAVID infusion 500 mg x 100ml (Alb. David)||$ 0.24|
|METRONIDAZOLE / CLARIS inj 500 mg x 100ml (Claris)||$ 0.23|
|METRONIDAZOLE / IVES infusion 500 mg x 100ml (Ives)|
|Metronidazole cream 7.5 mg/g (Prasco Laboratories (US))|
|Metronidazole injection, solution 500 mg/100mL (Hospira, Inc. (US))|
|Metronidazole gel 7.5 mg/g (Prasco Laboratories (US))|
|Metronidazole tablet 250 mg/1 (Physicians Total Care, Inc. (US))|
|Metronidazole tablet 500 mg/1 (REMEDYREPACK INC. (US))|
|Metronidazole lotion 7.5 mg/g (Prasco Laboratories (US))|
|Metronidazole tablet 250 mg (Aa Pharma Inc (Canada))|
|Metronidazole lotion 7.5 mg/mL (Actavis Mid Atlantic LLC, (US))|
|Metronidazole solution 500 mg/100mL (B. Braun Medical Inc. (US))|
|Metronidazole gel 10 mg/g (Taro Pharmaceuticals U.S.A., Inc. (US))|
|Metronidazole capsule 500 mg (Aa Pharma Inc (Canada))|
|Metronidazole tablet, film coated 250 mg/1 (Unichem Pharmaceuticals (USA, US), Inc.)|
|Metronidazole capsule 375 mg/1 (Heritage Pharmaceuticals Inc. (US))|
|Metronidazole tablet, film coated 500 mg/1 (Apotheca Inc. (US))|
List of Metronidazole substitutes (brand and generic names):
|Metronidazolas PharmaSwiss L (Lithuania)|
|Metronidazole - Behvazan 0.75%|
|Metronidazole - ShuGang Pharm (China)|
|Metronidazole - ShuGuang Pharm (China)|
|Metronidazole 0.5% Baxter (Cyprus)|
|Metronidazole 0.5% Polpharma (Slovakia)|
|METRONIDAZOLE 200 MG TABLET|
|METRONIDAZOLE 200 MG TABLET 1 strip / 10 tablets each (Jan Aushadhi)||$ 0.12|
|METRONIDAZOLE 400 MG TABLET|
|METRONIDAZOLE 400 MG TABLET 1 strip / 10 tablets each (Jan Aushadhi)||$ 0.25|
|Metronidazole 500mg/100ml Abbott (Kuwait)|
|Metronidazole 500mg/100mL Braun (Kuwait)|
|Metronidazole 500mg/100mL Pharma Solution (Kuwait)|
|Metronidazole A.N.H. (Thailand)|
|Metronidazole A.N.H. 200 mg x 500's|
|Metronidazole A.N.H. 200 mg x 1, 000's|
|Metronidazole AA Pharma (Canada)|
|Metronidazole ABR (Bulgaria)|
|Metronidazole Actavis (Hong Kong, Malta, United Kingdom, United States)|
|Metronidazole Actavis 200 mg x 250's|
|Metronidazole Adithya Pharma (Myanmar)|
|Metronidazole Alembic (United States)|
|Metronidazole Anhui Doulbe-Crane (Vietnam)|
|Metronidazole Anhui Doulbe-Crane 0.5 g/250 mL x 1 Bottle 250 mL|
|Metronidazole Aurobindo (United Kingdom)|
|Metronidazole B Braun (Czech Republic, Georgia, Greece, South Africa)|
|Metronidazole B Braun 500 g/100 mL x 1's|
|Métronidazole B. Braun (France)|
|Metronidazole B. Braun 1 Bottle 100 mL|
|Metronidazole B. Braun (Estonia, Greece, Latvia, South Africa)|
|Metronidazole B. Braun 1 Bottle 100 mL|
|Métronidazole B. Braun 0.5% (France)|
|Métronidazole Baxter (France)|
|Metronidazole Baxter 500 mg/100 mL x 1's|
|Metronidazole Baxter (Canada)|
|Metronidazole Baxter 500 mg/100 mL x 1's|
|Métronidazole Baxter 0.5% (France)|
|Metronidazole Bieffe (Greece)|
|Metronidazole Biopharm (Bulgaria)|
|Metronidazole Bioren (Switzerland)|
|Metronidazole Bioren 500mg/100ml (Switzerland)|
|Metronidazole Biosedra (Tunisia)|
|Injectable; Injection; Metronidazole 5 mg / ml|
|Métronidazole Biosedra (France)|
|Injectable; Injection; Metronidazole 5 mg / ml|
|Metronidazole Braun (Finland, Luxembourg, Sweden, Tunisia)|
|Metronidazole CCPC (Taiwan)|
|Metronidazole Chen Ho (Taiwan)|
|Metronidazole Cherubino (Malta)|
|Metronidazole Chia Tai Tianqing (China)|
- DailyMed. "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "metronidazole". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "metronidazole". http://www.drugbank.ca/drugs/DB00916 (accessed September 17, 2018).
ReviewsThe results of a survey conducted on ndrugs.com for Metronidazole are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Metronidazole. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported usefulNo survey data has been collected yet
Consumer reported price estimatesNo survey data has been collected yet
2 consumers reported time for resultsTo what extent do I have to use Metronidazole before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes > 3 month and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Metronidazole. To get the time effectiveness of using Metronidazole drug by other patients, please click here.
|> 3 month||1||50.0%|
5 consumers reported age
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology